Impact of Time of Injection on the Efficacy and Safety of iGlarLixi Versus IDegAsp in Chinese People With Type 2 Diabetes: Exploratory Analysis of the Soli-D Study. [PDF]
Li X +8 more
europepmc +1 more source
Comparative thromboembolic risk and polypharmacy-related drug-drug interaction signals among antidiabetic medications: a large-scale FAERS pharmacovigilance study. [PDF]
Bafail D, Ghazal H.
europepmc +1 more source
Ectopic Insulin-Derived Amyloidosis Arising in the Inguinal Region Distant From Injection Sites. [PDF]
Shimizu S +9 more
europepmc +1 more source
Physicochemical Stability of Insulin and Analogues in Saline Infusion: Screening for Amyloid and Amorphous High-Molecular-Weight Material. [PDF]
da Cruz E Silva JG +2 more
europepmc +1 more source
Impacts of national volume-based procurement policy on insulin price, volume and expenditure in China: a quasi-experimental study. [PDF]
Yi H, Tan S, Cai M, Kuai L, Xu D, Han S.
europepmc +1 more source
Regular human insulins versus rapid-acting insulin analogues in children and adolescents with type 1 diabetes: a systematic review with meta-analysis and trial sequential analysis. [PDF]
Petersen JJ +6 more
europepmc +1 more source
Successful rapid desensitization to multiple insulin preparations in an adult with type 1 diabetes: a case report and literature review. [PDF]
Chen Y, Zhu W, Chen G, Yao J.
europepmc +1 more source
Availability, prices and affordability of nationally negotiated antidiabetic medicines in China: a national survey. [PDF]
Tang W +6 more
europepmc +1 more source
A case report of young-onset type 2 diabetes patient with severe metabolic dysregulation carrying an <i>LRP6</i> variant. [PDF]
Xiang D, Yuan L, Liao S, Wang Y.
europepmc +1 more source
Ultra-Rapid Lispro Has an Improved Pharmacokinetic Profile for Exercise Compared With Lispro, Resulting in Less Exercise-Associated Hypoglycemia in Adults With Type 1 Diabetes on Open-Loop Continuous Subcutaneous Insulin Infusion. [PDF]
Leohr JK +6 more
europepmc +1 more source

